CA15P1: A Drug Target / Disease Biomarker (G100996435)

Target Name: CA15P1

NCBI ID: G100996435

Other Name(s): CA15 pseudogene 1 | Carbonic anhydrase 15 pseudogene 1

CA15P1: A Drug Target / Disease Biomarker

Cancer, a leading cause of human mortality, has a high mortality rate and is a significant public health issue. The most common type of cancer is breast cancer, which affects millions of women worldwide. The development and progression of breast cancer can be attributed to various factors, including genetic and environmental factors. The identification of potential drug targets and biomarkers for breast cancer has the potential to improve treatment outcomes and increase survival rates. One such potential drug target is CA15P1, which is a protein that is expressed in various types of cancer, including breast cancer.

CA15P1 is a transmembrane protein that is characterized by its ability to bind to a specific protein called CD73. CD73 is a protein that is expressed in various tissues, including the lungs, heart, and pancreas. The interaction between CD73 and CA15P1 has been shown to promote the formation of a complex called the CA15P1-CD73 complex. This complex is thought to play a role in the development and progression of various types of cancer, including breast cancer.

Studies have shown that high levels of CA15P1 expression are associated with poor prognosis in breast cancer patients. In addition, the CA15P1-CD73 complex has been shown to promote the growth and survival of various cancer cell types, including breast cancer cells. This suggests that CA15P1 may be a potential drug target for breast cancer.

One of the key challenges in the development of drug targets for breast cancer is the lack of understanding of its underlying biology. While the CA15P1-CD73 complex is known to be involved in the development and progression of cancer, it is not clear how it contributes to the disease. Further research is needed to understand the role of CA15P1 in breast cancer and to identify potential drug targets.

In addition to its potential as a drug target, CA15P1 has also been shown to be a potential biomarker for breast cancer. The CA15P1 protein is expressed in various types of cancer, including breast cancer, and has been shown to be associated with the development and progression of the disease. In addition, high levels of CA15P1 expression have been shown to be associated with poor prognosis in breast cancer patients. This suggests that CA15P1 may be a useful biomarker for the diagnosis and prognosis of breast cancer.

The identification and characterization of potential drug targets and biomarkers for breast cancer is an important step in the development of new treatments. While further research is needed to fully understand the role of CA15P1 in breast cancer, its potential as a drug target and biomarker is an exciting area of research that has the potential to improve treatment outcomes for breast cancer patients.

Protein Name: CA15 Pseudogene 1

More Common Targets